Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour, a multicenter retrospective cohort study

L Antonelli; A Heidenreich; A Bagrodia; N Branger; W Cazzaniga; TN Clinton; S Daneshmand; H Djaladat; S Eggener; RJ Hamilton; M Ho; WJ Sexton; S Nazzani; D Nicol; N Nicolai; K Olson; P Paffenholz; J Porter; N Singla; SP Stroup; Tachibana; Angelika Terbuch; C Cary; CD Fankhauser

Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour, a multicenter retrospective cohort study

L Antonelli
, A Heidenreich
, A Bagrodia
, N Branger
, W Cazzaniga
, TN Clinton
, S Daneshmand
, H Djaladat
, S Eggener
, RJ Hamilton
, M Ho
, WJ Sexton
, S Nazzani
, D Nicol
, N Nicolai
, K Olson
, P Paffenholz
, J Porter
, N Singla
, SP Stroup

Tachibana, Angelika Terbuch, C Cary, CD Fankhauser

Klinische Abteilung für Onkologie

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

Originalsprache	Englisch
Seiten (von - bis)	S722-S723
Seitenumfang	2
Fachzeitschrift	European Urology
Jahrgang	85
Publikationsstatus	Veröffentlicht - März 2024
Veranstaltung	39th Annual Meeting of the European Association of Urology - Paris, Frankreich Dauer: 5 Apr. 2024 → 8 Apr. 2024

Wissenschaftszweige

302 Klinische Medizin

Andere Dateien und Links

Web of Science

Dieses zitieren

Antonelli, L., Heidenreich, A., Bagrodia, A., Branger, N., Cazzaniga, W., Clinton, TN., Daneshmand, S., Djaladat, H., Eggener, S., Hamilton, RJ., Ho, M., Sexton, WJ., Nazzani, S., Nicol, D., Nicolai, N., Olson, K., Paffenholz, P., Porter, J., Singla, N., ... Fankhauser, CD. (2024). Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour, a multicenter retrospective cohort study. European Urology, 85, S722-S723.

@article{59e97e8723f541f89e24f3124850d0d3,

title = "Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour, a multicenter retrospective cohort study",

author = "L Antonelli and A Heidenreich and A Bagrodia and N Branger and W Cazzaniga and TN Clinton and S Daneshmand and H Djaladat and S Eggener and RJ Hamilton and M Ho and WJ Sexton and S Nazzani and D Nicol and N Nicolai and K Olson and P Paffenholz and J Porter and N Singla and SP Stroup and Tachibana and Angelika Terbuch and C Cary and CD Fankhauser",

year = "2024",

month = mar,

language = "English",

volume = "85",

pages = "S722--S723",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

note = "39th Annual Meeting of the European Association of Urology, EAU 39 ; Conference date: 05-04-2024 Through 08-04-2024",

}

Antonelli, L, Heidenreich, A, Bagrodia, A, Branger, N, Cazzaniga, W, Clinton, TN, Daneshmand, S, Djaladat, H, Eggener, S, Hamilton, RJ, Ho, M, Sexton, WJ, Nazzani, S, Nicol, D, Nicolai, N, Olson, K, Paffenholz, P, Porter, J, Singla, N, Stroup, SP, Tachibana, , Terbuch, A, Cary, C & Fankhauser, CD 2024, 'Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour, a multicenter retrospective cohort study', European Urology, Jg. 85, S. S722-S723.

TY - JOUR

T1 - Outcomes after primary retroperitoneal lymph node dissection in men with stage 2 non-seminomatous germ cell tumour, a multicenter retrospective cohort study

AU - Antonelli, L

AU - Heidenreich, A

AU - Bagrodia, A

AU - Branger, N

AU - Cazzaniga, W

AU - Clinton, TN

AU - Daneshmand, S

AU - Djaladat, H

AU - Eggener, S

AU - Hamilton, RJ

AU - Ho, M

AU - Sexton, WJ

AU - Nazzani, S

AU - Nicol, D

AU - Nicolai, N

AU - Olson, K

AU - Paffenholz, P

AU - Porter, J

AU - Singla, N

AU - Stroup, SP

AU - Tachibana, null

AU - Terbuch, Angelika

AU - Cary, C

AU - Fankhauser, CD

PY - 2024/3

Y1 - 2024/3

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001282821400517

M3 - Conference abstract

SN - 0302-2838

VL - 85

SP - S722-S723

JO - European Urology

JF - European Urology

T2 - 39th Annual Meeting of the European Association of Urology

Y2 - 5 April 2024 through 8 April 2024

ER -